Skip to main content

Advertisement

SpringerLink
Log in

Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Persistent/recurrent primary hyperparathyroidism (pHPT) occurs frequently in multiple endocrine neoplasia type 1 (MEN1). We assessed the usefulness of intraoperative PTH (IOPTH) and preoperative localizing studies based on the outcome of patients with MEN1-associated pHPT undergoing reoperative surgery.

Methods

A retrospective analysis identified MEN1 patients with persistent/recurrent pHPT. Patient outcome was defined as postoperative serum calcium and PTH levels (cured, persistent or recurrent) at last follow-up. Positive predictive value (PPV) was calculated for imaging studies and IOPTH.

Results

Thirty patients with MEN1-associated recurrent/persistent pHPT underwent 69 reoperative parathyroidectomies. Median follow-up time was 33 months. Persistent pHPT occurred in four (13 %) patients. IOPTH had a 92 % PPV for postoperative eucalcemia. Ultrasound and Tc99m-sestamibi had sensitivities of 100 and 85 % for localizing an enlarged parathyroid gland. However, five (17 %) patients had additional enlarged glands, not visualized preoperatively that were removed after IOPTH did not drop appropriately. Bone mineral density scores did not improve after reoperation (p = 0.60), but the rate of postoperative nephrocalcinosis did (p = 0.046). Patients with pancreatic neuroendocrine tumors had significantly higher rates of persistent/recurrent pHPT compared with those without (40 vs. 0 %, p = 0.021). Intraoperative and delayed parathyroid autotransplantation was performed in nine (30 %) and four (14 %) patients, respectively.

Conclusions

Although preoperative localizing studies are helpful for guiding reoperative strategy in MEN1 with persistent/recurrent pHPT, additional enlarged glands may be missed by conventional imaging. IOPTH should therefore be employed routinely in this setting. Routine cryopreservation should be considered in all patients. Pancreatic manifestation may be associated with earlier recurrence or persistent disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. 1. Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg. 2010;34(2):249–55.

    Article  PubMed  Google Scholar 

  2. 2. Lourenco DM, Jr., Toledo RA, Coutinho FL, Margarido LC, Siqueira SA, dos Santos MA, et al. The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1. Clinics. 2007;62(4):465–76.

    Article  PubMed  Google Scholar 

  3. 3. Pieterman CR, Schreinemakers JM, Koppeschaar HP, Vriens MR, Rinkes IH, Zonnenberg BA, et al. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Clin Endocrinol. 2009;70(4):575–81.

    Article  CAS  Google Scholar 

  4. 4. Waldmann J, Fendrich V, Habbe N, Bartsch DK, Slater EP, Kann PH, et al. Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. World J Sur. 2009;33(6):1208–18.

    Article  Google Scholar 

  5. Kraimps JL, Duh QY, Demeure M, Clark OH. Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery. 1992;112(6):1080–6; discussion 6–8.

  6. 6. Marx SJ, Menczel J, Campbell G, Aurbach GD, Spiegel AM, Norton JA. Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. Clin Endocrinol. 1991;35(6):521–6.

    Article  CAS  Google Scholar 

  7. Elaraj DM, Skarulis MC, Libutti SK, Norton JA, Bartlett DL, Pingpank JF, et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134(6):858–64; discussion 64–5.

  8. 8. Lee CH, Tseng LM, Chen JY, Hsiao HY, Yang AH. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol. 2006;13(1):103–9.

    Article  PubMed  Google Scholar 

  9. 9. Dotzenrath C, Cupisti K, Goretzki PE, Yang Q, Simon D, Ohmann C, et al. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg. 2001;167(3):173–8.

    Article  CAS  PubMed  Google Scholar 

  10. 10. Hellman P, Skogseid B, Oberg K, Juhlin C, Akerstrom G, Rastad J. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998;124(6):993–9.

    Article  CAS  PubMed  Google Scholar 

  11. O’Riordain DS, O’Brien T, Grant CS, Weaver A, Gharib H, van Heerden JA. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery. 1993;114(6):1031–7; discussion 7–9.

  12. 12. Rizzoli R, Green J, 3rd, Marx SJ. Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med. 1985;78(3):467–74.

    Article  CAS  PubMed  Google Scholar 

  13. 13. Carling T, Udelsman R. Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med. 2005;257(1):27–37.

    Article  CAS  PubMed  Google Scholar 

  14. 14. Hubbard JG, Sebag F, Maweja S, Henry JF. Primary hyperparathyroidism in MEN 1: how radical should surgery be? Langenbeck’s Arch Surg. 2002;386(8):553–7.

    Article  Google Scholar 

  15. 15. Kivlen MH, Bartlett DL, Libutti SK, Skarulis MC, Marx SJ, Simonds WF, et al. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2001;130(6):991–8.

    Article  CAS  PubMed  Google Scholar 

  16. 16. Langer P, Wild A, Schilling T, Nies C, Rothmund M, Bartsch DK. [Multiple endocrine neoplasia type 1. Surgical therapy of primary hyperparathyroidism]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 2004;75(9):900–6.

    Article  CAS  PubMed  Google Scholar 

  17. 17. Pieterman CR, van Hulsteijn LT, den Heijer M, van der Luijt RB, Bonenkamp JJ, Hermus AR, et al. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg. 2012;255(6):1171–8.

    Article  PubMed  Google Scholar 

  18. 18. Shepherd JJ, Burgess JR, Greenaway TM, Ware R. Preoperative sestamibi scanning and surgical findings at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1. Arch Surg. 2000;135(7):844–8.

    Article  CAS  PubMed  Google Scholar 

  19. 19. Feldman AL, Sharaf RN, Skarulis MC, Bartlett DL, Libutti SK, Weinstein LS, et al. Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery. 1999;126(6):1042–8.

    Article  CAS  PubMed  Google Scholar 

  20. Libutti SK, Alexander HR, Bartlett DL, Sampson ML, Ruddel ME, Skarulis M, et al. Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. Surgery. 1999;126(6):1145–50; discussion 50–1.

  21. 21. Norton JA, Cornelius MJ, Doppman JL, Maton PN, Gardner JD, Jensen RT. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger–Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery. 1987;102(6):958–66.

    CAS  PubMed  Google Scholar 

  22. 22. Borot S, Lapierre V, Carnaille B, Goudet P, Penfornis A. Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery. 2010;147(4):529–35.

    Article  PubMed  Google Scholar 

Download references

Disclosure

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Endocrine Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Xavier M. Keutgen (MD), Naris Nilubol (MD, FACS) & Electron Kebebew (MD, FACS)

  2. Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA

    Sunita Agarwal (PhD), James Welch (MGC), Craig Cochran (RN), Steve J. Marx (MD), Lee S. Weinstein (MD) & William F. Simonds (MD)

Authors
  1. Xavier M. Keutgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naris Nilubol
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sunita Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James Welch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Craig Cochran
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Steve J. Marx
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lee S. Weinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. William F. Simonds
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Electron Kebebew
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xavier M. Keutgen.

Additional information

Accepted for Poster Presentation at the American Association of Endocrine Surgery (AAES) Annual Meeting, Baltimore, MD, April 10–12, 2016.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 15 kb)

Supplementary material 2 (DOC 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Keutgen, X.M., Nilubol, N., Agarwal, S. et al. Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism. Ann Surg Oncol 23 (Suppl 5), 701–707 (2016). https://doi.org/10.1245/s10434-016-5467-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5467-x

Keywords

Search

Navigation